APA (7th ed.) Citation

A, R., M, V., E, V., P, B., S, B., S, R., . . . P, S. (2022). Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies. Frontiers in immunology, 13, 910136. https://doi.org/10.3389/fimmu.2022.910136

Chicago Style (17th ed.) Citation

A, Rice, et al. "Heterologous SaRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies." Frontiers in Immunology 13 (2022): 910136. https://doi.org/10.3389/fimmu.2022.910136.

MLA (9th ed.) Citation

A, Rice, et al. "Heterologous SaRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies." Frontiers in Immunology, vol. 13, 2022, p. 910136, https://doi.org/10.3389/fimmu.2022.910136.